Dionise Ysabelle Bawal, MD To describe the landscape of diabetes management for the past fifteen or so years as exciting would be an understatement
A study coming out in the next month or so is expected to show a 20% reduction in heart attacks, strokes, and death from a cardiovascular cause
These simple moves quickly reveal how a platform actually treats regular customers
GLP-1 medications are substantially more effective for glucose control
Evaluation often includes: Comprehensive ophthalmologic exam with optic disc assessment Visual field testing Optical coherence tomography (OCT) to assess optic nerve head and retinal nerve fiber layer Blood pressure assessment and cardiovascular risk review Laboratory testing if giant cell arteritis is suspected (commonly ESR, CRP, platelet count), and possible temporal artery evaluation based on clinical presentation Treatment options for NAION are limited, and practice varies
At 6 months, there was no significant change in median body weight between groups (L:2.6 kg, P:2.9 kg, p = 0.92, Table 2)